ORION OYJ
Last · Helsinki€86.85+4.10 (+4.95%)live · yahoo · 1h ago
Market cap€12.2B109.0M sh
P/E · TTM21.7fwd 18.3 · eps 4.01
Beta0.28vs S&P 500
Div yield2.09%annual · TTM
52w range
€56.50€86.70
Volume15.9Ksession
Loading chart…
Upcoming earnings
4:30 PM UTC+1
Period
Sep 2026
Est. EPS
$1.10
Est. revenue
537.2M
Earnings transcripts
- Issuer webcast
7/3/2026 Orion publishes Half-Year Report for January–June 2026 and holds a webcast on 17 July 2026
ORION OYJ
- Issuer webcast
7/3/2026 Orion publishes Half-Year Report for January–June 2026 and holds a webcast on 17 July 2026
Orion Oyj
- Issuer webcast
Q3 2018 webcast
ORION OYJ
- Issuer webcast
Q2 2012 webcast
ORION OYJ
- Issuer webcast
Q3 2010 webcast
ORION OYJ
- Issuer webcast
Q1 2025 webcast
ORION OYJ
Press & signals
- GlobeNewswire
125,000 Orion Corporation A shares converted into B shares
- GlobeNewswire
Orion Pharma announces agreement with Qilu Pharma Europe for pembrolizumab biosimilar for European market
- GlobeNewswire
Orion Pharma announces first patient dosed in Phase 1/2 clinical trial of ODM-216, the company’s first biologic candidate to reach clinical testing
The rest of this company's wire — with summaries and source links — is part of Pro.
See plansDocuments
FormReporting forFiledFlags